Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1958PDF: 780HTML: 196 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1625PDF: 626HTML: 2414 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3837PDF: 1444HTML: 9173Untitled: 259Untitled: 164Untitled: 149Untitled: 145Untitled: 163Untitled: 317 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3097PDF: 1103HTML: 1457Untitled: 159Untitled: 148Untitled: 150 -
-
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3177PDF: 1487HTML: 396 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1339PDF: 798HTML: 3104 -
-
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
977PDF: 976HTML: 87 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4221PDF: 1707HTML: 1095 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3165PDF: 1301HTML: 4106 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1692PDF: 546HTML: 262







